Navigation Links
Global Radiopharmaceutical Market 2012-2016 Reports
Date:11/14/2013

DALLAS, Nov. 14, 2013 /PRNewswire-iReach/ -- ReportsnReports.com adds Global Radiopharmaceutical Market 2012-2016 research report to its store.

(Photo: http://photos.prnewswire.com/prnh/20131114/MN17191)

Analysts forecast the Global Radiopharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market.

Global Radiopharmaceutical Market 2012-2016 report is available at http://www.reportsnreports.com/reports/270658-global-radiopharmaceutical-market-2012-2016.html.

The Global Radiopharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Radiopharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc.

Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=270658.

Key questions answered in these market research reports:

  1. What will the market size be in 2016 and what will be the growth rate?
  2. What are key market trends?
  3. What is driving this market?
  4. What are the challenges to market growth?
  5. Who are the key vendors in this market space?
  6. What are the market opportunities and threats faced by key vendors?
  7. What are the strengths and weaknesses of each of these key vendors?

Table of Contents:

  1. Executive Summary
  2. Scope of the Report
  3. Market Research Methodology
  4. List of Abbreviations
  5. Introduction
  6. Market Landscape
  7. Global Radiopharmaceuticals Market Segmentation by Application
  8. Geographical Segmentation
  9. Key Leading Countries
  10. Buying Criteria
  11. Market Growth Drivers
  12. Drivers and their Impact
  13. Market Challenges
  14. Impact of Drivers and Challenges
  15. Market Trends
  16. Trends and their Impact
  17. Vendor Landscape
  18. Other Reports in this Series

List of Exhibits provided in the Global Radiopharmaceutical Market Report include:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Radiopharmaceuticals Market 2012-2016 (US $ billion)

Exhibit 3: Global Radiopharmaceuticals Market Segmentation by Application

Exhibit 4: Global Radiopharmaceuticals Market Segmentation Based on Application 2012

Exhibit 5: Global Radiopharmaceuticals Market Segmentation Based on Application 2016

Exhibit 6: Global Diagnostic Radiopharmaceuticals Market 2012-2016 (US$ billion)

Exhibit 7: Global Therapeutics Radiopharmaceuticals Market 2012-2016 (US$ billion)

Exhibit 8: Global Radiopharmaceuticals Market by Geographical Segmentation 2012

Exhibit 9: Global Radiopharmaceuticals Market by Vendor Segmentation 2012

Exhibit 10: Business Segmentation of Covidien plc

Exhibit 11: Business Segmentation of Cardinal Healthcare Inc.

Exhibit 12: Business Segmentation of IBA Molecular Inc.

Explore more reports Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us:

ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details on sales@reportsandreports.com This e-mail address is being protected from spambots. You need JavaScript enabled to view it and we would be happy to help you find the business intelligence that you need. Not limited to the biotechnology industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, consumer goods, environment, medical devices, healthcare, food and beverages, retail, water, advanced materials and much more.

Media Contact: Priyank Tiwari, ReportsnReports, +1 888 391 5441, sales@reportsandreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ReportsnReports
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global X-ray Equipment Market to 2017 - Market Size, Growth, and Forecasts in Nearly 70 Countries
2. SPO Global Reports Results for Third Quarter 2013
3. Pre-Owned Medical Devices Market is Expected to Reach USD 4.9 Billion Globally in 2019: Transparency Market Research
4. Lilly Announces Significant Global Insulin Manufacturing Capacity Investments in Response to Growing Diabetes Epidemic
5. Competing in the Global Contract Manufacturing Market
6. Global and Chinese Medical MRI Equipment Industry Report 2013
7. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
8. WPPS GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline
9. Blood Banking And Blood Products - Global Strategic Business Report
10. 2013 Deep Research Report on Global and China Vitamin H Industry
11. 2012 Deep Research Report on Global and China Plastic Injection Molding Machine Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... and PETACH TIKVAH, Israel , Aug. ... a leading developer of adult stem cell technologies for ... ending June 30, 2017. ... for our pivotal Phase 3 trial to investigate NurOwn ... President and Chief Executive Officer of BrainStorm. "We have ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... 23, 2017 , ... Arizona Spine & Joint Hospital ... designation of High Performing Hospitals by U.S. News & World Report for knee replacement ... significantly better than the national average in a given procedure or condition.  , ...
(Date:8/23/2017)... ... August 23, 2017 , ... Virsys12, ... strategic growth plans, announcing the hiring of Kevin Keelan as a Senior Account ... seasoned sales manager, Keelan will be working with Virsys12 senior leadership to extend ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... unique masks and serums that perfectly fuse the beauty of naturally derived ingredients ... 2017 Indie Beauty Expo on August 23rd & 24th in New York City. ...
(Date:8/22/2017)... ... August 22, 2017 , ... Pivot Point Consulting, ... Zack Tisch as the firm’s new Consulting Services Executive. Mr. Tisch will oversee ... accounts, from assisting clients with initial vendor selection and pre-implementation planning through go-live ...
(Date:8/22/2017)... ... ... is new to the Texas market, but is proudly managed by widely recognized All Star ... in Grand Prairie, TX, located in the center of the DFW Metroplex, the fourth largest ... the past 40 years with 32 convenient locations in Texas, Nevada and California resulting in ...
Breaking Medicine News(10 mins):